GOVX
Companies
NASDAQ
Geovax Labs Inc.
Health Care
$0.92
-$1.52 (-61.45%)
Price Chart
Overview
About GOVX
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
Market Cap
$4.1M
Volume
202.0K
Avg. Volume
367.9K
P/E Ratio
-1.2093023
Dividend Yield
0.00%
Employees
21.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.81
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, GOVX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$4.1M
Volume202.0K
P/E Ratio-1.21
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025